INOGEN, INC. (NASDAQ:INGN) Files An 8-K Regulation FD Disclosure
Item 9.01.Regulation FD Disclosure
Investor Conferences
The officers of Inogen, Inc. (the “Company”) will participate in the 2019 J.P. Morgan Healthcare Conference in San Francisco, which begins on Monday, January 7, 2019 at 8:00am PT, and the 21st Annual Needham Growth Conference in New York City, which begins on Wednesday, January 16, 2019 at 8:00am ET.The Company’s officers are scheduled to present at the JP Morgan Healthcare Conference on Wednesday, January 9, 2019, at 3:30pm PT and at the Needham Growth Conference on Wednesday, January 16, 2019 at 2:10pm ET. During the conferences and in separate sessions with analysts and investors, our officers will refer to an updated slide presentation.A copy of this updated slide presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Included in this updated slide presentation is an updated inside sales representative headcount of 446 as of December 31, 2018 and certain additional information with respect to the oxygen therapy market. Interested parties can access the live audio webcast for both of these conference presentations from the Events section of the Investor Relations page on the Company’s website at www.inogen.com.
The information furnished to this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the “Securities Act”) or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01.Financial Statements and Exhibits
(d)Exhibits
|
Exhibit |
Description |
|
99.1 |
Investor Presentation |
EXHIBIT INDEX
|
Exhibit No. |
Description |
|
99.1 |
Investor Presentation |
Inogen Inc Exhibit
EX-99.1 2 ingn-ex991_41.htm EX-99.1 ingn-ex991_41.pptx.htm Company Overview January 2019 Exhibit 99.1 Notice regarding forward-looking statements These slides and the accompanying oral presentation (the “Presentation”) include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,…
To view the full exhibit click here
About INOGEN, INC. (NASDAQ:INGN)
Inogen, Inc. is a medical technology company. The Company is engaged in developing, manufacturing and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The Company’s Inogen One systems concentrate the air around the patient to offer a single source of supplemental oxygen anytime, anywhere with a portable device weighing approximately 4.8 or seven pounds. Its Inogen One G2 and Inogen One G3 have approximately five and 4.5 hours of battery life, respectively, with a single battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. The Inogen At Home stationary oxygen concentrator allows it to access the non-ambulatory patient market and serves as a backup to its Inogen One system for ambulatory patients. The Company sells its products to home medical equipment providers in the United States and in foreign countries.